Skip to NavigationSkip to content

News

The federal government has rescinded authorisation for one of the US’ biggest patient assistance charities following its discovery that the...
A new report has revealed that European biotech companies are “significantly outperforming” their US counterparts in terms of returning greater...
A team of researchers and biomedical engineers at Duke University have developed a fully functioning human heart muscle which can be manufactured...
Pfizer's erectile dysfunction treatment Viagra Connect (sildenafil) will now be available without a prescription through UK pharmacies, thanks to a...
Gilead has officially launched its hepatitis C drug Sovaldi (sofosbuvir) in the Chinese market, but with one major caveat: it will cost 58,980 yuan...
The FDA is looking to crack down on loopholes preventing generic versions of complex medical devices such as Mylan's EpiPen from reaching the market.
Merck KGaA and Pfizer have been rocked by the news that their jointly-developed anti-PD-L1 antibody failed to meet its primary endpoint in Phase 3...
A trio, including a former Senior Medical Representative at Novartis, have been charged over allegedly conspiring to offer and accept bribes of...
Researchers at the University of Virginia claim they have discovered a new target for triple-negative breast cancer, a notoriously aggressive and...
NICE has announced that it has rejected Eisai’s Halaven (eribulin) through draft guidance advising not to use the drug in locally advanced or ...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches